# MILES-3: Cisplatin in Combination With Gemcitabine for Elderly Patients With Lung Cancer

> **NCT01405586** · PHASE3 · UNKNOWN · sponsor: **National Cancer Institute, Naples** · enrollment: 299 (actual)

## Conditions studied

- Non-small Cell Lung Cancer Metastatic
- Non-small Cell Lung Cancer Stage IIIB

## Interventions

- **DRUG:** Gemcitabine
- **DRUG:** Gemcitabine
- **DRUG:** Cisplatin

## Key facts

- **NCT ID:** NCT01405586
- **Lead sponsor:** National Cancer Institute, Naples
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-03
- **Primary completion:** 2024-11
- **Final completion:** 2024-11
- **Target enrollment:** 299 (ACTUAL)
- **Last updated:** 2023-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01405586

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01405586, "MILES-3: Cisplatin in Combination With Gemcitabine for Elderly Patients With Lung Cancer". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT01405586. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*